Experience

Davis Polk advised Auris Medical Holding AG on a public offering of common shares and warrants. The common shares are listed on the NASDAQ Global Market under the symbol “EARS.” Auris…

Davis Polk advised Goosehead Insurance, Inc. on its $98.095 million initial public offering of 9,809,500 shares of Class A common stock, which includes the full exercise of the underwriters…

Davis Polk advised Banco Santander, S.A. in connection with its SEC-registered offering of $1.25 billion aggregate principal amount of 3.848% senior non-preferred fixed-rate notes due 2023,…

Davis Polk advised Affimed N.V. on its $26.5 million public offering of 13,225,000 of its common shares. Included in the shares are 1,725,000 shares sold by Affimed pursuant to the…

Davis Polk advised Auris Medical Holding AG on its registered direct offering of 12,499,999 of its common shares and concurrent private placement of warrants to purchase up to 7,499,999 of…

Davis Polk advised the financial adviser to GNC Holdings, Inc. in connection with the company’s offer to certain existing holders of its outstanding 1.50% convertible senior notes due 2020 …

Davis Polk advised Banco Santander Chile in connection with its Rule 144A and Regulation S offering of $500 million aggregate principal amount of its 2.500% senior fixed-rate notes due 2020…

Davis Polk advised the underwriter in connection with the $138.2 million secondary offering of 10,240,000 common shares of IRSA Propiedades Comerciales S.A. in the form of 2,560,000…

Davis Polk advised Banco Santander, S.A. in connection with its SEC-registered offering of $1 billion aggregate principal amount of 3.125% senior non-preferred fixed-rate notes due 2023, $1…

Davis Polk advised Auris Medical Holding AG in connection with the SEC-registered offering of $1.5 million of its common shares to Lincoln Park Capital Fund, LLC. The common shares are…